The Wellcome Sanger Institute, Helmholtz Munich, and Parse Biosciences have announced a landmark international collaboration ...

Genetic medicines could treat certain diseases, however, the current delivery systems available—viral vectors and lipid nanoparticles (LNPs)—pose unique challenges for gene therapy applications. For ...

Skin cancers in horses and humans show genetic similarities, but the animals are less prone to some other cancers, offering a ...

Collaboration combines Nuclera's eProtein Discovery System, which accelerates protein expression, purification and ...

In an open letter, researchers and staff at the National Institutes of Health raise concerns over recent policy changes.

Learn how the latest cutting-edge technology streamlines workflows and supports breakthroughs for some of the most ...

A protein from Helicobacter pylori inhibits amyloid formation in both microbes and humans, offering new leads for ...

David Hubel and Torsten Wiesel discovered how the cerebral cortex processes visual information. Their research won them the ...

Some microbes happily thrive in unforgiving environments. An extremophile hunt is underway to leverage their resilience ...

In his 40-year epidemiology career, Ian Lipkin has done it all: from discovering 2,000 viruses to solving a nationwide SARS ...

S ince 1961, there has been an ongoing cholera pandemic, with a rise in cases in 2022. Cholera, caused by the bacterium ...

In this webinar, Imogen Binnian will share how AI and gene synthesis technology can accelerate the discovery and validation ...